BRPI0612672B8 - composição de extrato aquoso de alga verde-azulada - Google Patents

composição de extrato aquoso de alga verde-azulada

Info

Publication number
BRPI0612672B8
BRPI0612672B8 BRPI0612672A BRPI0612672A BRPI0612672B8 BR PI0612672 B8 BRPI0612672 B8 BR PI0612672B8 BR PI0612672 A BRPI0612672 A BR PI0612672A BR PI0612672 A BRPI0612672 A BR PI0612672A BR PI0612672 B8 BRPI0612672 B8 BR PI0612672B8
Authority
BR
Brazil
Prior art keywords
selectin ligand
selectin
blue
composition
green algae
Prior art date
Application number
BRPI0612672A
Other languages
English (en)
Inventor
Drapeau Christian
S Jensen Gitte
Original Assignee
Cerule Llc
Desert Lake Tech
Desert Lake Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerule Llc, Desert Lake Tech, Desert Lake Tech Llc filed Critical Cerule Llc
Publication of BRPI0612672A2 publication Critical patent/BRPI0612672A2/pt
Publication of BRPI0612672B1 publication Critical patent/BRPI0612672B1/pt
Publication of BRPI0612672B8 publication Critical patent/BRPI0612672B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

extrato aquoso de aphanizomenon flos aquae, composição sólida, composição, ligante de selectina purificado isolado a partir de uma alga verde-azulada, composição farmacêutica, uso de um ligante de selectina purificado, uso de uma composição, método para isolar um ligante de selectina e ligante de selectina. a presente invenção refere-se a extratos de alga verde-azulada, tal como aphanizomenon fios aquae, que são enriquecidos por um ligante da selectina, tal como um ligante da l-selectina. os ligantes da selectina isola- dos de células de alga verde-azulada são descritos aqui. os métodos são descritos para isolar estes ligantes da selectina. os ligantes da selectina pu- rificada encontram uso na indução de mobilização de célula-tronco em um indivíduo. desta maneira, os métodos para induzir o isolamento de célula- tronco que incluem administrar uma quantidade terapeuticamente eficaz do extrato enriquecido formam o ligante da selectina, ou um ligante da selectina isolado.
BRPI0612672A 2005-06-24 2006-06-23 composição de extrato aquoso de alga verde-azulada BRPI0612672B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US69380805P 2005-06-24 2005-06-24
US60/693,808 2005-06-24
US70088205P 2005-07-19 2005-07-19
US60/700,882 2005-07-19
PCT/US2006/024769 WO2007002570A1 (en) 2005-06-24 2006-06-23 Purified component of blue-green algae and method of use

Publications (3)

Publication Number Publication Date
BRPI0612672A2 BRPI0612672A2 (pt) 2010-11-30
BRPI0612672B1 BRPI0612672B1 (pt) 2018-12-11
BRPI0612672B8 true BRPI0612672B8 (pt) 2021-05-25

Family

ID=37188001

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0612672A BRPI0612672B8 (pt) 2005-06-24 2006-06-23 composição de extrato aquoso de alga verde-azulada

Country Status (13)

Country Link
US (3) US7651690B2 (pt)
EP (1) EP1895973B1 (pt)
JP (1) JP5006877B2 (pt)
KR (1) KR101489728B1 (pt)
AU (1) AU2006261852B2 (pt)
BR (1) BRPI0612672B8 (pt)
CA (1) CA2612694C (pt)
ES (1) ES2546332T3 (pt)
HK (1) HK1114024A1 (pt)
IL (1) IL188192A (pt)
NZ (1) NZ565346A (pt)
RU (1) RU2417093C2 (pt)
WO (1) WO2007002570A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6814961B1 (en) 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
US8795679B2 (en) * 2006-05-05 2014-08-05 Blaa Lonid Hf Pharmaceutical and cosmetic use of extracts from algae obtainable from saline hot water sources
WO2008000431A2 (en) * 2006-06-27 2008-01-03 Nutratec S.R.L. Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositions containing the same
RU2441663C2 (ru) * 2006-06-27 2012-02-10 Нутратек С.Р.Л. Препарат aphanizomenon flos aquae, экстракты и очищенные компоненты экстрактов для лечения неврологических, нейродегенеративных и аффективных расстройств
US20080124318A1 (en) * 2006-11-28 2008-05-29 Jerold Lisson Algae supplement and treatment method
KR20100062140A (ko) * 2008-12-01 2010-06-10 부경대학교 산학협력단 푸코이단을 함유하는 골 형성 촉진 및 활성용 약학 조성물
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
US9370537B2 (en) 2009-04-03 2016-06-21 Cerule, Llc Compositions and methods for reducing inflammation
IT1394412B1 (it) * 2009-06-05 2012-06-15 Eni Spa Procedimento per l'essiccazione di biomassa algale
WO2011141906A2 (en) * 2010-05-11 2011-11-17 Benzion Geshuri Pharmaceutical composition comprising an algae adapted to increase the efficacy of an enzymatic inhibitor
US10159705B2 (en) 2010-06-28 2018-12-25 Stemtech IP Holdings, LLC Methods and compositions for enhancing stem cell mobilization
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
US8685845B2 (en) 2010-08-20 2014-04-01 International Business Machines Corporation Epitaxial growth of silicon doped with carbon and phosphorus using hydrogen carrier gas
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
WO2013074801A1 (en) 2011-11-18 2013-05-23 Stemtech International, Inc. Use of foti to enhance stem cell mobilization and proliferation
SG11201408083YA (en) * 2012-07-11 2015-01-29 Stemtech International Inc Compositions and methods for enhancing mobilization and proliferation of blastomere-like stem cells
EP2929013B1 (en) 2012-12-06 2020-02-05 Stembios Technologies, Inc. Lgr5+ somatic stem cells
EP2746769A1 (en) * 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
US20150141901A1 (en) * 2013-11-08 2015-05-21 Alan S. Lichtbroun Low-level laser irradiation of stimulated human stem cells
CA2932237C (en) 2013-12-03 2022-12-13 Gerolymatos International S.A. Ionic aqueous compositions comprising sulfated polysaccharides
CN107312063A (zh) * 2017-06-22 2017-11-03 乐清瑞耀食品技术有限公司 钝顶螺旋藻活性蛋白的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5663911A (en) 1979-10-29 1981-05-30 Dainippon Ink & Chem Inc Cosmetic containing hard-soluble phycocyanin
US6309639B1 (en) * 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
CA2404155C (en) * 2000-03-27 2011-08-09 Genetics Institute, Llc. Methods for purifying highly anionic proteins
US7205284B2 (en) * 2000-07-10 2007-04-17 University Of Mississippi Potent immunostimulants from microalgae
JP2002069443A (ja) * 2000-08-30 2002-03-08 Microalgae Corporation 抗酸化剤及び該抗酸化剤を含有する化粧料
DE60140903D1 (de) * 2000-10-18 2010-02-04 Brigham & Womens Hospital E-selectin/l-selectin-liganden-polypeptide hämatopoetischer zellen und verfahren zu deren verwendung
US6814961B1 (en) * 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
FR2850277B1 (fr) 2003-01-24 2005-04-08 Lanatech Composition comprenant un extrait d'aphanizomenon flos-aquae, son utilisation et sa preparation

Also Published As

Publication number Publication date
ES2546332T3 (es) 2015-09-22
IL188192A (en) 2014-04-30
US20070003647A1 (en) 2007-01-04
RU2417093C2 (ru) 2011-04-27
RU2008100847A (ru) 2009-07-27
US20100092507A1 (en) 2010-04-15
AU2006261852A1 (en) 2007-01-04
JP2008546808A (ja) 2008-12-25
KR20080030047A (ko) 2008-04-03
EP1895973B1 (en) 2015-08-19
US7947284B2 (en) 2011-05-24
CA2612694A1 (en) 2007-01-04
AU2006261852B2 (en) 2012-07-19
US20100209461A1 (en) 2010-08-19
JP5006877B2 (ja) 2012-08-22
EP1895973A1 (en) 2008-03-12
HK1114024A1 (zh) 2008-10-24
IL188192A0 (en) 2011-08-01
KR101489728B1 (ko) 2015-02-04
BRPI0612672A2 (pt) 2010-11-30
CA2612694C (en) 2015-10-27
WO2007002570A1 (en) 2007-01-04
US7651690B2 (en) 2010-01-26
BRPI0612672B1 (pt) 2018-12-11
NZ565346A (en) 2010-05-28

Similar Documents

Publication Publication Date Title
BRPI0612672B8 (pt) composição de extrato aquoso de alga verde-azulada
PE20061107A1 (es) Composiciones de tigeciclina y metodos para su preparacion
Sebastin Santhosh et al. Snake venom induced local toxicities: plant secondary metabolites as an auxiliary therapy
CO7010783A2 (es) Proteína naglu humana recombinante y usos de la misma
BRPI0412815A (pt) extrato de plantas com eficácia prebiótica
BRPI0609784C1 (pt) compostos éster de n-alquilcarbonil-aminoácido e n-alquilcarbonil-amino lactona, composição, e, uso de um composto
CO6880050A2 (es) Composiciones y metodos para controlar la fusariosis
BR112012030581A2 (pt) pseudozyma aphidis como um agente de biocontrole contra vários patógenos de plantas
BR112014001909A2 (pt) gene da toxina axmi270 e métodos para a sua utilização
AR101961A1 (es) Composiciones que comprenden células recombinantes de bacillus y otro agente de control biológico
BR112012022676A2 (pt) composição imunogênica, métodos para tratamento ou prevenção de infecção ou doença, para fabricar uma composição imunogênica e para melhorar uma vacina, e, kit
AR081450A1 (es) Tratamiento de sarcoidosis usando celulas madre de placenta
KR20210024688A (ko) 관절 건강을 위한 조성물 및 방법
BR112015014458A2 (pt) derivados de manose para o tratamento de infecções bacterianas
CA3070606A1 (en) Compositions and methods for increasing phytochemical bioavailablity and bioactivity
BR112012033548A2 (pt) métodos e composições para melhorar a mobilização de células-tronco
BR112012006283A2 (pt) formulação de adamts13 estabilizada, método para fabricar uma formulação de adamts13 estabilizada, kit, e métodos para tratar ou prevenir uma doença e para tratar ou previnir um enfarte
BR112014022166A2 (pt) gene da delta-endotoxina axmi345 e métodos para a sua utilização
BR112015018693A2 (pt) composições compreendendo um agente de controle biológico à base de streptomyces e um inseticida
ECSP20024456A (es) Uso de composiciones que contienen Streptomyces melanosporofaciens AGL225 en el control de enfermedades de las plantas
BR112014022034A2 (pt) gene da toxina axmi335 de bacillus thuringiensis e métodos para a sua utilização
UY32650A (es) Medicamento para la administración oral que contiene al menos un esterógeno y/o al menos un gestágeno y al menos una cepa de bacterias probióticas
BR112014011345A2 (pt) partículas tipo vírus da influenza (vlps) compreendendo nicotiana tabacum produzida por hemaglutinina
BRPI0715070B8 (pt) uso de escina na produção de preparados farmacêuticos para tratamento de doenças mediadas ou causadas por granulócitos ativados
TR201818784T4 (tr) Selenyum İle Kombinasyon Halinde Aronia Sp.'nin Bir Ekstraktını İçeren Bağışık Uyarıcı Terkip

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/12/2018, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: DESERT LAKE TECHNOLOGIES, LLC (US)

B25D Requested change of name of applicant approved

Owner name: CERULE, LLC (US)

B25D Requested change of name of applicant approved

Owner name: DESERT LAKE TECHNOLOGIES, LLC (US)

B25G Requested change of headquarter approved

Owner name: DESERT LAKE TECHNOLOGIES, LLC (US)

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/06/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2728 DE 18-04-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.